Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

11.17 -0.65 (-5.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 104,399
Open 11.57
Bid (Size) 8.650 (2)
Ask (Size) 13.00 (2)
Prev. Close 11.82
Today's Range 10.97 - 11.61
52wk Range 1.160 - 12.57
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine 
From GeneDx Holdings Corp.
Via GlobeNewswire
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire

Performance

YTD
+323.11%
+323.11%
1 Month
+31.72%
+31.72%
3 Month
+231.45%
+231.45%
6 Month
+268.65%
+268.65%
1 Year
+12.87%
+12.87%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Preview: GeneDx Hldgs
Via Benzinga
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
From GeneDx Holdings Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
GeneDx to Participate in 44th Annual Cowen Health Care Conference
From GeneDx Holdings Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
Earnings Scheduled For February 20, 2024
Via Benzinga
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx Holdings Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
GeneDx Announces Preliminary 2023 Financial Results
From GeneDx Holdings Corp.
Via GlobeNewswire
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
From GeneDx Holdings Corp.
Via GlobeNewswire
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
From GeneDx Holdings Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx Holdings Corp.
Via GlobeNewswire
Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
Via Benzinga
Topics Stocks
Exposures US Equities
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.